GLENMARK LIFE SCIENCES LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 834 INR | +0.73% |
|
+0.08% | +26.93% |
| May. 15 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
| Apr. 25 | Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
Evolution of the average Target Price on Glenmark Life Sciences Limited
Price target over the last 5 years
History of analyst recommendation changes
168e2293.B-PtvMWV57Sx3a12DCDrxauN2HkLTJO_pW77IjuwjA8.cKyI6qqmoIGA5McDdXKc9Z_IqRNHC6qM-j69an3x5WxtrILSsv_R9sWT7A~b146b6ae60087f4df7d1a5a1a01dcf69
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
834
INR
Average target price
905.8
INR
Spread / Average Target
+8.60%
High Price Target
993
INR
Spread / Highest target
+19.06%
Low Price Target
790
INR
Spread / Lowest Target
-5.28%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
D
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GLS Stock
- Consensus Glenmark Life Sciences Limited